TRPM4 is highly expressed in human colorectal tumor buds and contributes to proliferation, cell cycle, and invasion of colorectal cancer cells
Transient receptor potential melastatin‐4 channel (TRPM4) dysregulation contributes to heart conditions, immune diseases, and cervical and prostate cancer. Up to now, the involvement of TRPM4 in colorectal cancer (CRC) pathophysiology remains unknown. Here, we investigated tumor tissue microarrays f...
Saved in:
| Main Authors: | Sven Kappel, Paulina Stokłosa, Barbara Hauert, Daniela Ross‐Kaschitza, Anna Borgström, Roland Baur, José A. Galván, Inti Zlobec, Christine Peinelt |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2019-11-01
|
| Series: | Molecular Oncology |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/1878-0261.12566 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
CDX2 loss in colorectal cancer cells is associated with invasive properties and tumor budding
by: Nils Bodmer, et al.
Published: (2025-07-01) -
TRPM4 contributes to cell death in prostate cancer tumor spheroids, and to extravasation and metastasis in a zebrafish xenograft model system
by: Florian Bochen, et al.
Published: (2025-05-01) -
Tumor budding as a prognostic criterion of colorectal cancer
by: I. I. Yakovtsova, et al.
Published: (2021-12-01) -
Pathomorphological analysis of budding in colorectal carcinomas
by: I. S. Shponka, et al.
Published: (2023-08-01) -
The Impact of TRPM8 on Prostate Cancer Transcriptomic Dynamics
by: Swapna Asuthkar, et al.
Published: (2025-03-01)